Onderneming Conduit Pharmaceuticals Inc.
Aandelen
CDT
US20678X1063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,04 USD | +1,33% | +7,04% | -33,19% |
Vakgebied
Aantal werknemers: 7
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Tapolczay
CEO | Chief Executive Officer | 64 | 22-09-23 |
Adam Sragovicz
DFI | Director of Finance/CFO | 55 | 01-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Freda Lewis-Hall
CHM | Chairman | 69 | 22-09-23 |
Director/Board Member | 50 | 22-09-23 | |
Faith Charles
BRD | Director/Board Member | 62 | 22-09-23 |
Andrew Regan
BRD | Director/Board Member | 59 | 22-09-23 |
David Tapolczay
CEO | Chief Executive Officer | 64 | 22-09-23 |
Chele Farley
BRD | Director/Board Member | 56 | 22-09-23 |
James Bligh
BRD | Director/Board Member | 36 | 22-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 73 829 536 | 9 928 091 ( 13,45 %) | 0 | 13,45 % |
Bedrijfsgegevens
Conduit Pharmaceuticals, Inc.
4995 Murphy Canyon Road Suite 300
92123, San Diego
+
http://www.conduitpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-33,19% | 224 mln. | |
+43,36% | 54,63 mld. | |
-5,31% | 39,92 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. | |
-11,83% | 10,74 mld. |